文献速递生殖医学妇科

子宫内膜异位症患者卵母细胞玻璃化冷冻用于生育力保存的观察性研究

Oocyte vitrification for fertility preservation in women with endometriosis: an observational study.
PubMed 文献 · Fertil Steril · 2020-03-04

卵母细胞存活率83.2%,累积活产率46.4%;手术组获卵数较少,但手术对累积活产率无显著影响。年轻(≤35岁)未手术患者卵巢反应和累积活产率更高。

要点

  • 子宫内膜异位症患者卵母细胞玻璃化冷冻后存活率83.2%,累积活产率46.4%。
  • 年龄、冷冻卵母细胞数和存活率与累积活产率独立相关。
  • 年轻(≤35岁)未手术患者卵巢反应和累积活产率高于手术患者。

核心结论

  • 生育力保存为子宫内膜异位症患者提供了增加生育机会的有效治疗选择。
  • 建议年轻女性在促排卵行生育力保存后再行手术,年长女性应考虑个体化治疗。

研究设计与样本

  • 干预为玻璃化冷冻MII期卵母细胞以备未来使用,主要结局为卵母细胞存活率和累积活产率。

主要发现

  • 玻璃化冷冻时平均年龄35.7±3.7岁,手术组患者较未手术组年轻(33.4±3.6岁 vs. 36.7±3.7岁)。
  • 卵母细胞存活率和累积活产率分别为83.2%和46.4%。
  • 每周期冷冻卵母细胞数未手术组(6.2±5.8)高于单侧手术组(5.0±4.5)或双侧手术组(4.5±4.4),手术组间相当。
  • 年龄(调整OR 0.904;95%CI 0.858-0.952)、卵母细胞数(调整OR 1.050;95%CI 1.025-1.091)和存活率(调整OR 1.011;95%CI 1.001-1.020)对累积活产率的影响得到确认,手术的影响未观察到(调整OR 1.142;95%CI 0.778-1.677)。
  • 年轻(≤35岁)未手术患者较手术患者卵巢反应(冷冻卵母细胞数8.6±6.9 vs. 5.1±4.8)和累积活产率(72.5% vs. 52.8%)更高,年长女性结局相似。

临床怎么用

  • 对子宫内膜异位症患者,卵母细胞玻璃化冷冻是可行的生育力保存方式。
  • 年轻女性可考虑在促排卵生育力保存后再行手术。
  • 年长女性需个体化决策。

局限性

  • 回顾性观察性研究,可能存在选择偏倚。
  • 单中心研究,结果外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To describe the outcome of fertility preservation (FP) using vitrified oocytes in patients with endometriosis and to determine the impact of ovarian surgery. DESIGN: Retrospective observational study. SETTING: University-affiliated private in vitro fertilization (IVF) center. PATIENT(S): Four hundred and eighty-five women with endometriosis who underwent FP from January 2007 to July 2018. INTERVENTION(S): Vitrification of metaphase II (MII) oocytes for future use. MAIN OUTCOME MEASURE(S): Oocyte survival rate and cumulative live-birth rate (CLBR). RESULT(S): Mean age at vitrification was 35.7 ± 3.7 years. The women undergoing operations were younger than the nonsurgical patients (33.4 ± 3.6 years vs. 36.7 ± 3.7 years). The survival rate and CLBR were 83.2% and 46.4%, respectively. The number of vitrified oocytes per cycle (6.2 ± 5.8) was higher for the nonsurgical patients compared with the unilateral (5.0 ± 4.5) or bilateral (4.5 ± 4.4) surgery groups, but was comparable among the surgical patients. The effect of age (adjusted odds ratio [OR] 0.904; 95% CI, 0.858-0.952), number of oocytes (adjusted OR 1.050; 95% CI, 1.025-1.091), and survival (adjusted OR 1.011; 95% CI, 1.001-1.020) on the CLBR was confirmed. However, the effect of surgery was not observed (adjusted OR 1.142; 95% CI, 0.778-1.677). Nonetheless, the ovarian response (vitrified oocytes = 8.6 ± 6.9 vs. 5.1 ± 4.8) and CLBR (72.5% vs. 52.8%) were higher in young (≤35 years) nonsurgical patient versus the surgical patients; older women showed similar outcomes. CONCLUSION(S): Fertility preservation gives patients with endometriosis a valid treatment option to help them increase their reproductive chances. We suggest performing surgery after ovarian stimulation for FP in young women. In older women, an individualized treatment should be considered.

来源:Fertil Steril,查看原文。版权归原作者所有。

引用

  1. Cobo A, Giles J, Paolelli S, et al. Oocyte vitrification for fertility preservation in women with endometriosis: an observational study. Fertil Steril. 2020. PMID: 32145929. doi:10.1016/j.fertnstert.2019.11.017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。